Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » 2024 Brisbane NET Patient Forum Recap

2024 Brisbane NET Patient Forum Recap

  • June 18, 2024

On Monday 17th June 2024. NECA facilitated the first NET Forum of the year and the Brisbane Convention and Exhibition Centre, Queensland. It was great to see familiar some faces and new patients/family and friends.

We had an amazing turn out of roughly 30 attendees which included patients, family/carers, and healthcare professionals. Our program included a diverse range of topics :

  • We had a welcome, introductions and a NECA presentation from our CEO Meredith Cummins,
  • Associate Professor David Wyld, Medical Oncologist at The Royal Brisbane & Women’s Hospital gave an overview of AUSNET/STOPNET trials.
  • Dr Mark Nalder, Medical Oncologist at The Royal Brisbane & Women’s Hospital gave an overview of Lung NETs and NETs in general.
  • Associate Professor David Pattison is currently the Deputy Director of the Department of Nuclear Medicine & Specialised PET Services, nuclear medicine lead for The Royal Brisbane & Women’s Hospital’s radionuclide therapy service, he provided an insightful overview on PRRT (Peptide Receptor Radionuclide Therapy) and nuclear medicine updates.
  • Dr Lorcan Ruane is a cardiologist with a special interest in Cardio-Oncology and Carcinoid Heat Disease and working at The Prince Charles Hospital who gave an overview of carcinoid heart disease, the effects on the heart and respective treatments.
  • Meredith then facilitated Q & A time, which included great discussions regarding upcoming treatments, new scanning technology vs the scanning technology, which is commonly used now to diagnose NETs, just to name a few.

Thank you to everyone who attended the Brisbane NET Patient Forum and a big thank you to our guest speakers. This session was recorded and will be available on our website in the coming weeks, please keep an eye out on our social media for when the link is made available. We look forward to returning in two years for the next Forum.

Share this post

Recent posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025

NECA Strategy Day 2025

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousHigh Tea Fundraiser
NextCancer Nurses Society of Australia (CNSA) 2024 CongressNext

Related Posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

NECA Strategy Day 2025

On Wednesday 21 May, NeuroEndocrine Cancer Australia (NECA) hosted our annual Strategy Day in Sydney. It’s the one day each year when our entire team

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin